Taken together, these bioinformatic results indicated that the anti-cancer function of Amuc_C primarily stems from its ability to induce inflammatory responses, activating subsequent immune cell activation, as well as causing cell cycle arrest (G1/S) and inhibiting cell proliferation caused by upregulation of p53 and downregulation of the Rho family pathway. This evidence concerns the gene TP53 and cancer.